Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Investment in real estate:    
Land $ 152,060 $ 128,857
Building 985,091 851,427
Site improvements 19,021 15,183
Tenant improvements 58,900 49,204
Acquired lease intangible assets 127,931 98,234
Investment in real estate, Total 1,343,003 1,142,905
Less: accumulated depreciation and amortization (143,255) (94,462)
Investment in real estate, net 1,199,748 1,048,443
Cash and cash equivalents 7,213 5,507
Restricted cash 5,546 5,246
Tenant receivables, net 6,070 5,596
Due from related parties 163 103
Escrow deposits 5,957 4,817
Deferred assets 25,417 20,272
Derivative asset 1,236 0
Goodwill 5,903 5,903
Other assets 6,232 5,019
Total assets 1,263,485 1,100,906
Liabilities:    
Credit Facility, net of unamortized debt issuance costs of $8,033 and $3,559 at December 31, 2021 and December 31, 2020, respectively 514,567 521,641
Notes payable, net of unamortized debt issuance costs of $607 and $835 at December 31, 2021 and December 31, 2020, respectively 57,162 64,937
Accounts payable and accrued expenses 10,344 7,279
Dividends payable 15,668 12,470
Security deposits 4,540 4,340
Due to related party 0 0
Derivative liability 7,790 18,086
Other liabilities 7,709 6,171
Acquired lease intangible liability, net 8,128 8,222
Total liabilities 625,908 643,146
Commitments and Contingencies
Equity:    
Preferred stock, $0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at December 31, 2021 and December 31, 2020, respectively (liquidation preference of $77,625 at December 31, 2021 and December 31, 2020, respectively) 74,959 74,959
Common stock, $0.001 par value, 500,000 shares authorized; 64,880 shares and 49,461 shares issued and outstanding at December 31, 2021 and December 31, 2020, respectively 65 49
Additional paid-in capital 711,414 504,789
Accumulated deficit (157,017) (116,773)
Accumulated other comprehensive loss (6,636) (18,219)
Total Global Medical REIT Inc. stockholders' equity 622,785 444,805
Noncontrolling interest 14,792 12,955
Total equity 637,577 457,760
Total liabilities and equity $ 1,263,485 $ 1,100,906